Impact of Pushrim Activated Power Assist Wheelchairs on Mobility Among People With Tetraplegia
Study Details
Study Description
Brief Summary
The purpose of this three phase study is to evaluate a Pushrim Activated Power Assist Wheelchair (PAPAW). Phase I will examine whether the steady-state, metabolic energy efficiency for propelling a manual wheelchair with and without the device will be significantly different. In Phase II, wheelchair users will evaluate the PAPAW over activities of daily living course to determine its usability and acceptability and to identify areas for future development. Finally, in phase III, comparison of activities of daily living in the community will be made between the subjects when using their personal wheelchair and a PAPAW.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Objectives:
The purpose of this three phase study is to evaluate a Pushrim Activated Power Assist Wheelchair (PAPAW). Phase I will examine whether the steady-state, metabolic energy efficiency for propelling a manual wheelchair with and without the device will be significantly different. In Phase II, wheelchair users will evaluate the PAPAW over activities of daily living course to determine its usability and acceptability and to identify areas for future development. Finally, in phase III, comparison of activities of daily living in the community will be made between the subjects when using their personal wheelchair and a PAPAW.
Research Design:
This is a repeated measures design type study, conducted in different locations for each phase: a biomechanics laboratory, an ADL driving course, and the participants' home environment. Analyzed variables include: metabolic energy expenditures, stroke frequency, upper extremity joint range of motion, participant responses to a visual analog survey, average speed, and actual daily driving time spent in either wheelchair, and daily distance traveled. Subjects will act as their own controls.
Methodology:
Full-time wheelchair users with tetraplegia between the ages of 18 and 65 will be recruited for the study. They will be free of pressure sores, free from any shoulder pain that would prevent them from propelling a manual wheelchair, and have no history of cardiopulmonary disease. A maximum of 50 subjects (fifteen for Phase I and II, and 15 or Phase III, and five for subject drop-out) will be recruited. In Phase I, participants will be asked to propel a PAPAW and their own wheelchair, attached to a wheelchair roller system through three resistance conditions. In Phase II, participants will be asked to propel both wheelchairs over activities of daily living. Finally, Phase III consists of a four-week trial including a two-week test with subjects' own wheelchairs (i.e. own chair trial) and a two-week test where they were provided with the PAPAW (i.e. PAPAW trial). The order of the own chair trial and the PAPAW trial will be randomized.
Clinical Relationship:
For individuals with tetraplegia, PAPAWs reduce energy demands, stroke frequency, and overall joint range of motion when compared to traditional manual wheelchair propulsion. In addition, PAPAWs have the potential to improve the functional capabilities during certain activities of daily living as well as community participation of individuals with tetraplegia. Use of this device could help maintain overall physical capacity while reducing the risk for pain and injuries to the upper extremities.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Pushrim Activated Power Assist Wheelchair Participants will be asked to propel both their own chair and a pushrim activated power assist wheelchair on a computer controlled wheelchair dynamometer. |
Device: Pushrim Activated Power Assist
The PAPAW is an electrically-powered add-on unit for common manual wheelchairs. The unit automatically supplements the users manual pushrim input with additional rear-wheel torque for up to six kilometers/hour traveling velocity. The amount of added torque is provided proportional to the user input to the pushrims. Movement and braking assistance is provided for both forward and rearward travel. Several types and sizes are available based on users operating strength, needs and anthropometry. The PAPAWs to be tested during this study will be the JWII (Yamaha Motor Corporation).
|
Outcome Measures
Primary Outcome Measures
- Oxygen Consumption [in-lab visit when propelling on a computer controlled wheelchair dynamometer]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
18 and 65 years of age
-
Full time wheelchair user
-
Diagnosis of Tetraplegia
Exclusion Criteria:
-
Pressure sores
-
Shoulder pain that would prevent them from propelling a manual wheelchair
-
History of cardiopulmonary disease.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Human Engineering Research Laboratories | Pittsburgh | Pennsylvania | United States | 15206 |
Sponsors and Collaborators
- VA Pittsburgh Healthcare System
Investigators
- Principal Investigator: Rory A Cooper, PhD, Human Engineering Research Laboratories
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 01103, 010842
- H133N000019
Study Results
Participant Flow
Recruitment Details | |
---|---|
Pre-assignment Detail |
Arm/Group Title | Pushrim Activated Power Assist Wheelchair |
---|---|
Arm/Group Description | Participants will be asked to propel both their own chair and a pushrim activated power assist wheelchair on a computer controlled wheelchair dynamometer. Pushrim Activated Power Assist: The PAPAW is an electrically-powered add-on unit for common manual wheelchairs. The unit automatically supplements the users manual pushrim input with additional rear-wheel torque for up to six kilometers/hour traveling velocity. The amount of added torque is provided proportional to the user input to the pushrims. Movement and braking assistance is provided for both forward and rearward travel. Several types and sizes are available based on users operating strength, needs and anthropometry. The PAPAWs to be tested during this study will be the JWII (Yamaha Motor Corporation). |
Period Title: Overall Study | |
STARTED | 45 |
COMPLETED | 45 |
NOT COMPLETED | 0 |
Baseline Characteristics
Arm/Group Title | Pushrim Activated Power Assist Wheelchair |
---|---|
Arm/Group Description | Participants will be asked to propel both their own chair and a pushrim activated power assist wheelchair on a computer controlled wheelchair dynamometer. Pushrim Activated Power Assist: The PAPAW is an electrically-powered add-on unit for common manual wheelchairs. The unit automatically supplements the users manual pushrim input with additional rear-wheel torque for up to six kilometers/hour traveling velocity. The amount of added torque is provided proportional to the user input to the pushrims. Movement and braking assistance is provided for both forward and rearward travel. Several types and sizes are available based on users operating strength, needs and anthropometry. The PAPAWs to be tested during this study will be the JWII (Yamaha Motor Corporation). |
Overall Participants | 45 |
Age (Count of Participants) | |
<=18 years |
0
0%
|
Between 18 and 65 years |
45
100%
|
>=65 years |
0
0%
|
Sex: Female, Male (Count of Participants) | |
Female |
10
22.2%
|
Male |
35
77.8%
|
Region of Enrollment (participants) [Number] | |
United States |
45
100%
|
Outcome Measures
Title | Oxygen Consumption |
---|---|
Description | |
Time Frame | in-lab visit when propelling on a computer controlled wheelchair dynamometer |
Outcome Measure Data
Analysis Population Description |
---|
personal w/c (.9 m/s, 10 W) |
Arm/Group Title | Pushrim Activated Power Assist Wheelchair |
---|---|
Arm/Group Description | Participants were asked to propel both their own chair and a pushrim activated power assist wheelchair on a computer controlled wheelchair dynamometer. |
Measure Participants | 15 |
Mean (Standard Deviation) [VO2 (ml/min)] |
625
(316)
|
Title | Oxygen Consumption |
---|---|
Description | |
Time Frame | in-lab visit when propelling on a computer controlled wheelchair dynamometer |
Outcome Measure Data
Analysis Population Description |
---|
PAPAW (.9 m/s, 10 W) |
Arm/Group Title | Pushrim Activated Power Assist Wheelchair |
---|---|
Arm/Group Description | Participants were asked to propel both their own chair and a pushrim activated power assist wheelchair on a computer controlled wheelchair dynamometer. |
Measure Participants | 15 |
Mean (Standard Deviation) [VO2 (ml/min)] |
415
(204)
|
Adverse Events
Time Frame | ||
---|---|---|
Adverse Event Reporting Description | ||
Arm/Group Title | Pushrim Activated Power Assist Wheelchair | |
Arm/Group Description | Participants were asked to propel both their own chair and a pushrim activated power assist wheelchair on a computer controlled wheelchair dynamometer. Pushrim Activated Power Assist: The PAPAW is an electrically-powered add-on unit for common manual wheelchairs. The unit automatically supplements the users manual pushrim input with additional rear-wheel torque for up to six kilometers/hour traveling velocity. The amount of added torque is provided proportional to the user input to the pushrims. Movement and braking assistance is provided for both forward and rearward travel. Several types and sizes are available based on users operating strength, needs and anthropometry. The PAPAWs to be tested during this study will be the JWII (Yamaha Motor Corporation). | |
All Cause Mortality |
||
Pushrim Activated Power Assist Wheelchair | ||
Affected / at Risk (%) | # Events | |
Total | / (NaN) | |
Serious Adverse Events |
||
Pushrim Activated Power Assist Wheelchair | ||
Affected / at Risk (%) | # Events | |
Total | 0/45 (0%) | |
Other (Not Including Serious) Adverse Events |
||
Pushrim Activated Power Assist Wheelchair | ||
Affected / at Risk (%) | # Events | |
Total | 0/45 (0%) |
Limitations/Caveats
More Information
Certain Agreements
Principal Investigators are NOT employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Rory Cooper, PhD |
---|---|
Organization | Human Engineering Research Laboratories |
Phone | 412-822-3700 |
rcooper@pitt.edu |
- 01103, 010842
- H133N000019